LG Chem Partners with UK's LabGenius Therapeutics for Novel Antibody Cancer Drug Development
LG化学6月18日宣布与英国LabGenius Therapeutics公司达成合作，签署了有关多种抗体抗癌新药候选物质的共同研发及行使选择权合作协议。LG化学将向LabGenius支付预付款和研发费用等。未来，双方将依据共同研究结果决定是否行使后续开发及授权许可。（财联社）
LG Chem has entered into a collaboration agreement with UK-based LabGenius Therapeutics to jointly develop novel antibody candidates for cancer drugs. Under the terms of the agreement, LG Chem will provide upfront payments and research funding to LabGenius. Both companies will collaborate on research, with options for further development and licensing based on the outcomes.
This partnership signifies a strategic move in the pharmaceutical industry, combining expertise to accelerate the development of potentially life-saving cancer treatments.
📌 Kaynak
Bu haber XML kaynağından derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →